Press Releases from Enzymicals AG (5 total)
Enzymicals AG Expands Off-the-Shelf Enzyme Collection: Unlocking Boundless Biote …
Greifswald (Germany), June 19th, 2023 - Enzymicals AG, a German enterprise focusing on industrial biocatalysis, announces a significant expansion of its enzyme collection through in-house activities and third-party collaborations. Leveraging one of the world's largest collections of naturally occurring and synthetically useful biocatalysts, the company now offers comprehensive screening services to identify excellent enzymes with a high probability of success. With its chemical expertise, Enzymicals can directly translate screening hits…
Novel enzymes produced by antibiotic-free fermentation technology are now in a r …
Scaling up success: Novel enzymes produced by antibiotic-free fermentation technology are now in a routine supply.
Greifswald (Germany) & Seraing (Belgium), April 27, 2023 - Enzymicals and Syngulon present an update about their non-exclusive license agreement of May 2020 on the use of Syngulon's antibiotic-free technology to produce enzymes. After successful completion of an R&D phase and the start of large-scale production, the developed enzyme products are now in a routine…
Enzyme Technology Alliance to offer protein and enzymatic process R&D from early …
The demand for sustainable yet scalable protein solutions is rising in the Pharmaceutical and Industrial Biotechnology sectors worldwide. The journey from a DNA or protein sequence to a valuable chemo-enzymatic process to deploy at scale requires broad expertise in R&D and manufacturing to bring such projects to success.
The newly formed Enzyme Technology Alliance allows start-ups and corporations globally to access the full scope of protein development to marketable products.…
Solvias and Enzymicals join forces in contract research, development and sustain …
Greifswald, Germany – November 24, 2021 - Enzymicals, one of the most experienced companies in Germany for in-vitro biosynthesis with biocatalytic process development and up-scaling expertise, today announced a non-exclusive partnership with Solvias (Kaiseraugst, Switzerland) opening access to alternative synthetic technology platforms for chemocatalysis and biocatalysis.
The ligands and specialty unit at Solvias has a proven track record for the efficient and successful development of catalytic processes while Enzymicals, a…
EMBLEM and Enzymicals AG announce a license and collaboration agreement to impro …
Heidelberg & Greifswald (Germany), February 22nd 2021 – EMBLEM Technology Transfer GmbH and Enzymicals AG enter into a partnership on the use of innovative computational tools to feed the company’s product pipeline.
EMBLEM Technology Transfer GmbH, the exclusive technology transfer partner of the European Molecular Biology Laboratory (EMBL), Europe’s flagship laboratory in the life sciences, and Enzymicals AG, a German enterprise focusing on industrial biocatalysis, today announce a non-exclusive license and…
